Bajaj Gurtej, Gupta Gaurav, Southerland Warren A, Southren Daniel
Physical Medicine and Rehabilitation, University of Pennsylvania, Philadelphia, USA.
Anesthesiology and Critical Care/Pain Medicine, Hospital of the University of Pennsylvania, Philadelphia, USA.
Cureus. 2022 Dec 29;14(12):e33098. doi: 10.7759/cureus.33098. eCollection 2022 Dec.
A spinal cord stimulator (SCS) is an excellent therapeutic strategy for many refractory chronic pain cases. They have a multi-faceted effect in providing relief in such indicated cases that include complex regional pain syndrome (CRPS) or failed back surgery syndrome (FBSS). However, if a patient has chronic intractable neuropathic pain outside the standard indications for SCS, can a case be made for trialing SCS as a last resort option? We describe a case where a patient with neuropathic groin pain, refractory to numerous types of procedures and non-interventional modalities, successfully underwent SCS therapy as a last resort option.
脊髓刺激器(SCS)是治疗许多难治性慢性疼痛病例的一种出色策略。在包括复杂性区域疼痛综合征(CRPS)或腰椎手术失败综合征(FBSS)等所示病例中,它们在缓解疼痛方面具有多方面的作用。然而,如果患者患有超出SCS标准适应症范围的慢性顽固性神经性疼痛,是否可以将SCS试验作为最后的选择呢?我们描述了这样一个病例,一名患有神经性腹股沟疼痛的患者,对多种类型的手术和非介入性治疗方法均无效,最终作为最后的选择成功接受了SCS治疗。